Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
Not Applicable
Completed
- Conditions
- Overactive Bladder
- Interventions
- Drug: Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 191
- Registration Number
- NCT01499069
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Genome-wide Association Study
Withdrawn
- Conditions
- Esophageal Squamous Cell Carcinoma
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT01498757
- Locations
- π°π·
Samsung medical Center, Seoul, Korea, Republic of
Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence
Not Applicable
Completed
- Conditions
- Mixed Urinary Incontinence
- Interventions
- Procedure: Midurethral slings (MUS)
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 137
- Registration Number
- NCT01493401
- Locations
- π°π·
The Catholic University of Korea College of Medicine, Bucheon St. Mary's Hospital, Bucheon, Korea, Republic of
π°π·Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Discontinuation Order of Vasopressors in Septic Shock
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2015-01-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 78
- Registration Number
- NCT01493102
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Biomarker Analysis of Gastrointestinal Cancer
- Conditions
- Gastrointestinal Cancer
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 500
- Registration Number
- NCT01484444
- Locations
- π°π·
Samsung medical Center, Seoul, Korea, Republic of
Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy
Phase 3
- Conditions
- Uterine MyomaUterine Adenomyosis
- Interventions
- Procedure: Single incision Laparoscopic hysterectomyProcedure: Conventional laparoscopic hysterectomy
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 240
- Registration Number
- NCT01483417
- Locations
- π°π·
Catholic Incheon Hospital, Incheon, Korea, Republic of
π°π·Yonsei University Medical Center, Seoul, Korea, Republic of
π°π·Keimyung University Dongsan Hospital, Deagu, Korea, Republic of
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
Completed
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01481805
- Locations
- π°π·
Samsung medical Center, Seoul, Korea, Republic of
Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy
Completed
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 35
- Registration Number
- NCT01482182
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
Completed
- Conditions
- Renal Cell CarcinomaHepatocellular Carcinoma
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01482520
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
- Conditions
- Lung Adenocarcinoma
- Interventions
- Other: CT, PET, copy number alteration
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01482585
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath